The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 13 May 2003
doi: 10.1242/jcs.00470
Research Article
CD105 prevents apoptosis in hypoxic endothelial cells
Chenggang Li,
Razao Issa,
Pat Kumar,
Ian N. Hampson,
Jose M. Lopez-Novoa,
Carmelo Bernabeu,
and
Shant Kumar*
* Author for correspondence (e-mail: mddpscl2{at}fs1.scg.man.ac.uk)
CD105, a marker of endothelial cells, is abundantly expressed in tissues undergoing angiogenesis and is a receptor for transforming growth factor 
. The pivotal role of CD105 in the vascular system was demonstrated by the severe vascular defects that occur in CD105-knockout mice, but the exact mechanisms for CD105 regulation of vascular development have not been fully elucidated. In light of the function of CD105 and the importance of hypoxia in neovascularisation, we speculated that CD105 is involved in hypoxia-initiated angiogenesis. Using tissue-cultured human microvascular endothelial cells, we have investigated the effects of hypoxic stress on CD105 gene expression. Hypoxia induced a significant increase in membrane-bound and secreted CD105 protein levels. CD105 mRNA and promoter activity were also markedly elevated, the latter returning to the basal level after 16 hours of hypoxic stress. Hypoxia induced cell cycle arrest at the G0/G1 phases and massive cell apoptosis after 24 hours through a reduction in the Bcl-2 to Bax ratio, downregulation of Bcl-XL and Mcl-1, and upregulation of caspase-3 and caspase-8. The consequence of CD105 upregulation was revealed using an antisense approach and a TUNEL assay. Suppression of CD105 increased cell apoptosis under hypoxic stress in the absence of TGF1. Furthermore, hypoxia and TGF1 synergistically induced apoptosis in the CD105-deficient cells but not in the control cells. We conclude that hypoxia is a potent stimulus for CD105 gene expression in vascular endothelial cells, which in turn attenuates cell apoptosis and thus contributes to angiogenesis.
This article has been cited by other articles:
|
|
|
|
 
Q. Lu
Transforming growth factor-{beta}1 protects against pulmonary artery endothelial cell apoptosis via ALK5
Am J Physiol Lung Cell Mol Physiol,
July 1, 2008;
295(1):
L123 - L133.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Munaut, S. Lorquet, C. Pequeux, S. Blacher, S. Berndt, F. Frankenne, and J.-M. Foidart
Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast
Hum. Reprod.,
June 1, 2008;
23(6):
1407 - 1415.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. A. Dallas, S. Samuel, L. Xia, F. Fan, M. J. Gray, S. J. Lim, and L. M. Ellis
Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy
Clin. Cancer Res.,
April 1, 2008;
14(7):
1931 - 1937.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Velasco, P. Alvarez-Munoz, M. Pericacho, P. t. Dijke, C. Bernabeu, J. M. Lopez-Novoa, and A. Rodriguez-Barbero
L- and S-endoglin differentially modulate TGF{beta}1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts
J. Cell Sci.,
March 15, 2008;
121(6):
913 - 919.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Nishimura, J. Komiyama, Y. Tasaki, T. J. Acosta, and K. Okuda
Hypoxia Promotes Luteal Cell Death in Bovine Corpus Luteum
Biol Reprod,
March 1, 2008;
78(3):
529 - 536.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Gilbert, M. J. Ryan, B. B. LaMarca, M. Sedeek, S. R. Murphy, and J. P. Granger
Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction
Am J Physiol Heart Circ Physiol,
February 1, 2008;
294(2):
H541 - H550.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Moody, S. Singbrant, G. Karlsson, U. Blank, M. Aspling, J. Flygare, D. Bryder, and S. Karlsson
Endoglin Is Not Critical for Hematopoietic Stem Cell Engraftment and Reconstitution but Regulates Adult Erythroid Development
Stem Cells,
November 1, 2007;
25(11):
2809 - 2819.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Muenzner, M. Rohde, S. Kneitz, and C. R. Hauck
CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells
J. Cell Biol.,
August 29, 2005;
170(5):
825 - 836.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Lebrin, M. Deckers, P. Bertolino, and P. ten Dijke
TGF-{beta} receptor function in the endothelium
Cardiovasc Res,
February 15, 2005;
65(3):
599 - 608.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Sanz-Rodriguez, A. Fernandez-L., R. Zarrabeitia, A. Perez-Molino, J. R. Ramirez, E. Coto, C. Bernabeu, and L. M. Botella
Mutation Analysis in Spanish Patients with Hereditary Hemorrhagic Telangiectasia: Deficient Endoglin Up-regulation in Activated Monocytes
Clin. Chem.,
November 1, 2004;
50(11):
2003 - 2011.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-T. Lin, C.-C. Chang, S.-T. Chen, H.-L. Chang, J.-L. Su, Y.-P. Chau, and M.-L. Kuo
Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-{kappa}B-dependent XIAP Up-Regulation
J. Biol. Chem.,
June 4, 2004;
279(23):
24015 - 24023.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Guo, S. Kumar, C. Li, M. Slevin, and P. Kumar
CD105 (Endoglin), Apoptosis, and Stroke
Stroke,
May 1, 2004;
35(5):
e94 - e95.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. C. Sullivan, L. Huminiecki, J. W. Moore, J. J. Boyle, R. Poulsom, D. Creamer, J. Barker, and R. Bicknell
EndoPDI, a Novel Protein-disulfide Isomerase-like Protein That Is Preferentially Expressed in Endothelial Cells Acts as a Stress Survival Factor
J. Biol. Chem.,
November 21, 2003;
278(47):
47079 - 47088.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2003
